Pharmaviva Ltd
308 High Street Croydon CR0 1NG
Number: 04364244
Incorporation date: 2002-01-31
Dissolution date: 2020-11-10
End of financial year: 31 December
Category: Private Limited Company
Status: Dissolved
Registered as 04364244 twenty two years ago, Pharmaviva Limited had been a private limited company until 2020-11-10 - the date it was dissolved. Its last known registration address was 308 High Street, Croydon Croydon.
This specific limited company was supervised by a single managing director: Asger N. who was administering it for 9 years.
Asger N. was the individual with significant control over this firm, had substantial control or influence over the company.
| Profit & Loss | |||||||
|---|---|---|---|---|---|---|---|
| Date of Accounts | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 |
| Currency | |||||||
| Net Worth | 37 628 | 67 192 | 70 433 | 23 049 | 27 464 | ||
| Balance Sheet | |||||||
| Current Assets | 49 595 | 77 916 | 87 288 | 45 374 | 64 895 | 61 780 | 68 560 |
| Net Assets Liabilities | 27 464 | 16 780 | 17 330 | ||||
| Cash Bank In Hand | 2 959 | 4 925 | 1 221 | 2 571 | |||
| Debtors | 44 391 | 72 026 | 86 067 | 42 803 | |||
| Net Assets Liabilities Including Pension Asset Liability | 37 628 | 67 192 | 70 433 | 23 049 | 27 464 | ||
| Stocks Inventory | 2 245 | 965 | |||||
| Tangible Fixed Assets | 1 485 | 2 127 | 1 253 | 379 | |||
| Capital & Reserves | |||||||
| Called Up Share Capital | 2 000 | 2 000 | 2 000 | 2 000 | |||
| Profit Loss Account Reserve | 35 628 | 65 192 | 68 433 | 21 049 | |||
| Shareholder Funds | 37 628 | 67 192 | 70 433 | 23 049 | 27 464 | ||
| Other Financial Data | |||||||
| Creditors | 37 431 | 45 000 | 51 230 | ||||
| Net Current Assets Liabilities | 36 143 | 65 065 | 69 180 | 22 670 | 27 464 | 16 780 | 17 330 |
| Total Assets Less Current Liabilities | 37 628 | 67 192 | 70 433 | 23 049 | 27 464 | 16 780 | 17 330 |
| Creditors Due Within One Year | 13 452 | 12 851 | 18 108 | 22 704 | 37 431 | ||
| Fixed Assets | 1 485 | 2 127 | 1 253 | 379 | |||
| Number Shares Allotted | 2 000 | 2 000 | 2 000 | ||||
| Par Value Share | 1 | 1 | 1 | ||||
| Share Capital Allotted Called Up Paid | 2 000 | 2 000 | 2 000 | 2 000 | |||
| Tangible Fixed Assets Additions | 1 516 | ||||||
| Tangible Fixed Assets Cost Or Valuation | 3 370 | 4 886 | 4 886 | 4 886 | |||
| Tangible Fixed Assets Depreciation | 1 885 | 2 759 | 3 633 | 4 507 | |||
| Tangible Fixed Assets Depreciation Charged In Period | 874 | 874 | 874 | ||||
Role: Director
Appointed: 16 March 2011
Latest update: 16 July 2023
| Account next due date | 31 December 2020 |
| Account last made up date | 31 December 2018 |
| Confirmation statement next due date | 02 February 2020 |
| Confirmation statement last made up date | 19 January 2019 |
| Annual Accounts 24 September 2014 | |
|---|---|
| Start Date For Period Covered By Report | 2013-01-01 |
| End Date For Period Covered By Report | 2013-12-31 |
| Date Approval Accounts | 24 September 2014 |
| Annual Accounts 23 September 2015 | |
| Start Date For Period Covered By Report | 2014-01-01 |
| End Date For Period Covered By Report | 2014-12-31 |
| Date Approval Accounts | 23 September 2015 |
| Annual Accounts 29 September 2016 | |
| Start Date For Period Covered By Report | 2015-01-01 |
| End Date For Period Covered By Report | 2015-12-31 |
| Date Approval Accounts | 29 September 2016 |
| Annual Accounts 21 November 2017 | |
| Start Date For Period Covered By Report | 2016-01-01 |
| End Date For Period Covered By Report | 2016-12-31 |
| Date Approval Accounts | 21 November 2017 |
| Annual Accounts | |
| Start Date For Period Covered By Report | 2017-01-01 |
| End Date For Period Covered By Report | 2017-12-31 |
| Annual Accounts | |
| Start Date For Period Covered By Report | 2018-01-01 |
| End Date For Period Covered By Report | 2018-12-31 |
(2 pages)